APA

Liénard D., Eggermont A. M., Schraffordt Koops H., Kroon B. B., Rosenkaimer F., Autier P. & Lejeune F. J. (19940823). Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. : Melanoma research.

Chicago

Liénard D, Eggermont A M, Schraffordt Koops H, Kroon B B, Rosenkaimer F, Autier P and Lejeune F J. 19940823. Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. : Melanoma research.

Harvard

Liénard D., Eggermont A. M., Schraffordt Koops H., Kroon B. B., Rosenkaimer F., Autier P. and Lejeune F. J. (19940823). Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. : Melanoma research.

MLA

Liénard D, Eggermont A M, Schraffordt Koops H, Kroon B B, Rosenkaimer F, Autier P and Lejeune F J. Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. : Melanoma research. 19940823.